Antibody

385개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved385 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleRochePhase 3

GP2013 - A Proposed biosimilar rituximab (GP2013 - A Proposed biosimilar rituximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleAbbViePhase 3

adalimumab biosimilar (GP2017, GP2017 (adalimumab biosimilar))

Ankylosing Spondylitis · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 1Status Active
AntibodyLimited DatastaleSandozPhase 3

adalimumab (Humira, GP2017 Adalimumab)

Plaque Type Psoriasis · Plaque Type Psoriasis

#PlaqueTypePsoriasis#Antibody#Phase3#monoclonal-antibody#Sandoz
Trials 1Status Active
AntibodyLimited DatastaleQuantumLeap Healthcare Collabor…Phase 2

GSK 5733584 + Dostarlimab (GSK 5733584 + Dostarlimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 1Status Recruiting
AntibodyLimited DatastaleSuzhou Kintor Pharmaceutical In…Phase 2

nivolumab (Opdivo, GT90001 and Nivolumab)

Metastatic Hepatocellular Carcinoma; HCC · Metastatic Hepatocellular Carcinoma

#MetastaticHepatocellularCarcinom#Antibody#Phase2#monoclonal-antibody#HCC+1
Trials 1Status Active
AntibodyLimited DatastaleInsel Gruppe AG, University Hos…Phase 2

durvalumab (Imfinzi, Gemcitabin, Cisplatin and Durvalumab)

Bile Duct Cancer · Bile Duct Cancer

#BileDuctCancer#Antibody#Phase2#monoclonal-antibody#Insel
Trials 1Status Recruiting
AntibodyLimited DatastaleHenan Provincial People's Hospi…Preclinical

Gene evolution and molecular response under Bevacizumab treatment (Gene evolution and molecular response under Bevacizumab treatment)

Genetic Change · Genetic Change

#GeneticChange#Antibody#Preclinical#monoclonal-antibody#Henan
Trials 1Status Recruiting
AntibodyLimited DatastaleHookipa Biotech GmbHPhase 2

pembrolizumab (Keytruda, HB-202 / HB-201 alternating intravenous administration + pembrolizumab.)

HPV-Related Squamous Cell Carcinoma · HPV-Related Squamous Cell Carcinoma

#HPV-RelatedSquamousCellCarcinoma#Antibody#Phase2#monoclonal-antibody#Hookipa
Trials 1Status Active
AntibodyLimited DatastaleCancer Research UKPhase 2

atezolizumab (Tecentriq, HTL0039732 Capsules and atezolizumab infusion)

Neoplasms; Prostatic Neoplasms, Castration-Resistant · Neoplasms

#Neoplasms#Antibody#Phase2#monoclonal-antibody#ProstaticNeoplasms+2
Trials 1Status Recruiting
AntibodyLimited DatastaleShuhong YiPhase 2

atezolizumab (Tecentriq, Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab)

Recurrent Liver Cancer After Liver Transplantation · Recurrent Liver Cancer After Liver Trans

#RecurrentLiverCancerAfterLiverTr#Antibody#Phase2#monoclonal-antibody#Shuhong
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

trastuzumab (Herceptin, Herceptin (trastuzumab))

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#Antibody#Preclinical#monoclonal-antibody#Roche
Trials 1Status Discontinued
AntibodyLimited DatastaleHunan Province Tumor HospitalPhase 2

IBI-323 combined with bevacizumab plus Platinum (IBI-323 combined with bevacizumab plus Platinum)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase2#monoclonal-antibody#Hunan
Trials 1Status Active
AntibodyLimited DatastaleIkena OncologyPhase 1

nivolumab (Opdivo, IK-175 and nivolumab)

Urothelial Carcinoma; Urothelial Carcinoma Bladder · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase1#monoclonal-antibody#UrothelialCarcinomaBladder+1
Trials 1Status Active
AntibodyLimited DatastaleGregory DanielsPhase 2

nivolumab (Opdivo, IL-2 and Nivolumab)

Melanoma Stage Iv; Renal Cell Carcinoma, Metastatic · Melanoma Stage Iv

#MelanomaStageIv#Antibody#Phase2#monoclonal-antibody#RenalCellCarcinoma+2
Trials 1Status Discontinued
AntibodyLimited DatastaleJanssenPhase 3

Induction dose of (Induction dose of, Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin)

Hepatitis C, Chronic · Hepatitis C, Chronic

#HepatitisCChronic#Antibody#Phase3#monoclonal-antibody#HepatitisC+2
Trials 1Status Active
AntibodyLimited DatastalePfizerPhase 3

Inotuzumab (Inotuzumab)

Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#Antibody#Phase3#monoclonal-antibody#Pfizer
Trials 1Status Discontinued
AntibodyLimited DatastaleNorthwell HealthPhase 1

trastuzumab (Herceptin, Intra-arterial Cerebral Infusion of Trastuzumab)

Neoplasm Metastasis · Neoplasm Metastasis

#NeoplasmMetastasis#Antibody#Phase1#monoclonal-antibody#Northwell
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 2

Intra-arterial Cetuximab (Intra-arterial Cetuximab)

Glioblastoma; Anaplastic Astrocytoma · Glioblastoma

#Glioblastoma#Antibody#Phase2#monoclonal-antibody#AnaplasticAstrocytoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 3

Intraarticular injection of infliximab (Intraarticular injection of infliximab)

Arthritis · Arthritis

#Arthritis#Antibody#Phase3#monoclonal-antibody#Janssen
Trials 1Status Discontinued
AntibodyLimited DatastaleKhon Kaen UniversityPhase 3

Intralesional injection of bevacizumab (Intralesional injection of bevacizumab)

Pterygium; Inflammation · Pterygium

#Pterygium#Antibody#Phase3#monoclonal-antibody#Inflammation+1
Trials 1Status Active

11 / 20 pages

← PreviousNext →